Sphingosine kinase type 1 inhibitors and uses thereof
US-9974758-B2 · May 22, 2018 · US
US10364211B1 · US · B1
| Field | Value |
|---|---|
| Publication number | US-10364211-B1 |
| Application number | US-201816169056-A |
| Country | US |
| Kind code | B1 |
| Filing date | Oct 24, 2018 |
| Priority date | Oct 25, 2017 |
| Publication date | Jul 30, 2019 |
| Grant date | Jul 30, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides methods for synthesizing the compound (2R,3S,4E)-N-methyl-5-(4′-pentylphenyl)-2-aminopent-4-ene-1,3-diol, also known as SK1-I, and intermediate compounds used in its synthesis.
Opening claim text (preview).
What is claimed is: 1. A method for synthesizing the compound comprising the reaction steps of: (vii) reacting with DIBAL in the presence of Rochelle salt, thereby obtaining
with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms · CPC title
and containing six-membered aromatic rings · CPC title
from amines with formation of carbamate groups · CPC title
Optical isomers · CPC title
by reactions not involving the formation of carbamate groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.